Skip to content
OpenCapital
Get started

Bolt Biotherapeutics, Inc. BOLT Q4 2024 Annual earnings

Reported March 24, 2025 · Before market open

Revenue$10.0KMiss by $780.0K
EPS-$7.60In line
Revenue estimate$790.0K
EPS estimate-$7.60

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$500.0K
EPS estimate-$3.39

Versus estimates

Revenue

Q1 2026$26.0KMiss by $1.5MQ4 2025$2.5MBeat by $1.8MQ3 2025$2.2MBeat by $1.3MQ2 2025$1.8MBeat by $958.2KQ1 2025$1.2MBeat by $454.5K
Q4 2024$10.0KMiss by $780.0K

Diluted EPS

Q1 2026-$4.31Miss by $1.46Q4 2025-$3.84Beat by $0.46Q3 2025-$3.72Beat by $1.35Q2 2025-$4.46Beat by $1.94Q1 2025-$5.80Beat by $1.00
Q4 2024-$7.60In line

Ask the moment Bolt Biotherapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bolt Biotherapeutics, Inc. report Q4 2024 earnings?
Bolt Biotherapeutics, Inc. (BOLT) reported Q4 2024 earnings on March 24, 2025 before market open.
What were Bolt Biotherapeutics, Inc.'s Q4 2024 revenue and EPS?
Bolt Biotherapeutics, Inc. reported revenue of $10.0K and eps of $-7.60 for Q4 2024.
Did Bolt Biotherapeutics, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $790.0K by $780.0K. EPS beat the consensus estimate of $-7.60 by $0.00.
Where can I find Bolt Biotherapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-043873) directly on SEC EDGAR. The filing index links above go to sec.gov.